Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$596M |
| 2 |
Meta Platforms (Facebook)
META
|
+$524M |
| 3 |
Microsoft
MSFT
|
+$415M |
| 4 |
Dominion Energy
D
|
+$358M |
| 5 |
Amazon
AMZN
|
+$358M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HEICO Corp Class A
HEI.A
|
+$764M |
| 2 |
Vale
VALE
|
+$427M |
| 3 |
SIVB
SVB Financial Group
SIVB
|
+$397M |
| 4 |
NBIS
Nebius Group N.V.
NBIS
|
+$376M |
| 5 |
ONC
BeOne Medicines Ltd
ONC
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.68% |
| 2 | Healthcare | 12.92% |
| 3 | Financials | 11.76% |
| 4 | Industrials | 11.1% |
| 5 | Consumer Discretionary | 10.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARVL
3551
DELISTED
Arrival Ordinary Shares
ARVL
| $130K | ﹤0.01% |
+19,472
| New | +$287K |
|
3552
InflaRx
IFRX
$295M
| $124K | ﹤0.01% |
63,995
+9,486
| +17% | +$20.5K |
|
|
AMRS
3553
DELISTED
Amyris Inc.
AMRS
| $119K | ﹤0.01% |
87,427
+6,885
| +9% | +$9.84K |
|
3554
The Beachbody Company
BODI
$45.8M
| $116K | ﹤0.01% |
4,822
-103
| -2% | -$3.19K |
|
3555
Grupo Aval
AVAL
$6.24B
| $115K | ﹤0.01% |
49,338
-1,220
| -2% | -$2.88K |
|
|
XNET
3556
Xunlei
XNET
$321M
| $113K | ﹤0.01% |
+61,218
| New | +$120K |
|
|
DOMA
3557
DELISTED
Doma Holdings, Inc.
DOMA
| $112K | ﹤0.01% |
10,995
-8
| -0.1% | -$108 |
|
|
CTLP
3558
DELISTED
Cantaloupe
CTLP
| $112K | ﹤0.01% |
19,611
-26,626
| -58% | -$142K |
|
3559
Rigel Pharmaceuticals
RIGL
$785M
| $110K | ﹤0.01% |
8,354
-8,596
| -51% | -$137K |
|
|
TOUR
3560
Tuniu
TOUR
$56.1M
| $108K | ﹤0.01% |
+5,793
| New | +$116K |
|
3561
NexGen Energy
NXE
$7.08B
| $107K | ﹤0.01% |
28,025
-5,935
| -17% | -$25.5K |
|
|
ENFN
3562
DELISTED
Enfusion, Inc.
ENFN
| $107K | ﹤0.01% |
+10,181
| New | +$112K |
|
|
IGR
3563
CBRE Global Real Estate Income Fund
IGR
$702M
| $106K | ﹤0.01% |
20,056
-7,142
| -26% | -$44.5K |
|
3564
Evolv Technologies
EVLV
$1.08B
| $105K | ﹤0.01% |
33,666
-1,987
| -6% | -$5.67K |
|
3565
Lindblad Expeditions
LIND
$2.15B
| $102K | ﹤0.01% |
10,688
-650
| -6% | -$6.54K |
|
|
RPTX
3566
DELISTED
Repare Therapeutics
RPTX
| $102K | ﹤0.01% |
+10,315
| New | +$118K |
|
3567
Lexicon Pharmaceuticals
LXRX
$1.08B
| $99.6K | ﹤0.01% |
40,972
-251
| -0.6% | -$575 |
|
3568
OmniAb
OABI
$491M
| $97.8K | ﹤0.01% |
26,588
-62,158
| -70% | -$235K |
|
3569
Vivid Seats
SEAT
$84.4M
| $97.7K | ﹤0.01% |
640
-1,053
| -62% | -$165K |
|
3570
Nerdy
NRDY
$95M
| $96.6K | ﹤0.01% |
23,106
+1,198
| +5% | +$3.66K |
|
3571
Ramaco Resources Class A
METC
$647M
| $96.2K | ﹤0.01% |
11,281
-14,111
| -56% | -$132K |
|
3572
Tango Therapeutics
TNGX
$4.44B
| $94.8K | ﹤0.01% |
24,005
-189,278
| -89% | -$1.1M |
|
3573
Atara Biotherapeutics
ATRA
$80.6M
| $94K | ﹤0.01% |
1,297
-1,543
| -54% | -$150K |
|
|
LNAI
3574
Lunai Bioworks
LNAI
$10.9M
| $92.4K | ﹤0.01% |
1,262
-6
| -0.5% | -$528 |
|
3575
Wipro
WIT
$19.5B
| $91.3K | ﹤0.01% |
40,666
-42,532
| -51% | -$101K |
|
Similar funds
Invesco's Q1 2023 Portfolio in Review
As of Q1 2023, Invesco held 4,112 positions worth $358B, up 5% from $341B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Invesco's Q1 2023 filing shows 101 new, 1,789 increased, 1,808 reduced and 253 closed positions. Its largest new stake was GE HealthCare: 3,173,709 shares worth $260M. The largest sale was HEICO Corp Class A, an estimated $764M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Invesco's largest Q1 2023 buy was GE HealthCare: 3,173,709 shares worth $260M.
- Invesco added most to Apple in Q1 2023, an estimated $596M increase.
- Invesco's biggest Q1 2023 reduction was HEICO Corp Class A, cutting an estimated $764M.
- Invesco fully exited SVB Financial Group in Q1 2023, selling an estimated $397M.
- Invesco's ten largest holdings make up 13% of its $358B portfolio in Q1 2023.
- Invesco opened 101 new positions and closed 253 in Q1 2023.
- Invesco's portfolio value rose 5% quarter-over-quarter to $358B.
Based on Invesco's 13F filing for Q1 2023, filed 12 May 2023.